SpaceX's Share Unlock Sank the Stock. Analysts Say Buy It Anyway.
SpaceX stock fell in pre-market trading on August 20 as 319 million shares held by early employees and investors became eligible to trade — the second major unlock in just two weeks, following a 911 million share release on August 6. On the day of the unlock, the stock dropped as much as 5.6%, briefly touching $131.86 and wiping roughly $103 billion in market value. By week's end, shares were trading only slightly above the $135 IPO price. The staggered nine-stage lockup structure was designed to dilute the impact of the enormous number of shares held by insiders — but even veteran backers aren't keen on making predictions about where this ends.
That's the headline everyone grabbed. Here's the part most of the takes left on the table:
What's not in dispute: the full 180-day lockup doesn't expire until December 8, 2026, and the August 6 release — 911.5 million shares, more than 20% of the entire restricted block — effectively more than doubled the publicly tradable float in a single day. After that comes the 180-day full expiry in December, when insiders and institutional holders can sell as much as they like — a wave that would almost certainly create serious downward pressure.
What is in dispute: whether the relentless drip of new supply will ultimately crush long-term shareholders, or whether SpaceX's growth engine is powerful enough to make the dilution irrelevant.
On one side, the bears have a straightforward case. A flood of new shares hitting the open market is a headwind the stock will have to fight for most of the rest of 2026 and into 2027 — and even after its pullback, SpaceX still carries a market cap of around $1.7 trillion for a company that generated less than $19 billion in revenue in 2025. DZ Bank analyst Markus Leistner initiated coverage with a Sell rating and a $100 price target, warning of "crash risk in the valuation orbit." Morningstar cut its fair value estimate to $62, citing "sizable dilution" from SpaceX's all-stock Cursor acquisition.
On the other, the bulls point to the numbers behind the noise. SpaceX reported second-quarter revenue of $7.8 billion, up 92% year over year, with its space segment up 29% and its Starlink connectivity business surging roughly 66%. When the larger 911 million share unlock hit on August 6, the stock rose more than 6% that day — supply shock absorbed, conviction intact. Bernstein analyst Douglas Harned responded to the August 20 unlock by raising his price target to $248, implying over 85% upside from current levels. Morgan Stanley's Adam Jonas calls SpaceX a "potential generational compounder" with a $300 target.
The gap between those two camps is not a rounding error. The $200 spread between the most bearish and most bullish analyst targets exceeds SpaceX's entire trading range since it went public.
Which leaves the question that actually matters, and the one no price target can settle for you:
Is SpaceX's share dilution a slow bleed that will quietly hollow out long-term investor value — or is it just the growing pain of the world's most ambitious company finally going public?
The models in the Arena are split on it. We dropped the question in and let them argue it out. Watch below.
Will SpaceX's staggered share dilution ultimately destroy long-term shareholder value, or will growth absorb the supply pressure?
Listen to the full debate ►The roughly 43% probability assessments circulating around SpaceX's IPO mechanics suggest the market itself is uncertain about how post-lockup sell pressure resolves, and even optimistic models showing index funds absorbing perhaps a quarter of the float by day fifteen still leave substantial overhang that punishes early believers. 🔍 Visionary growth narratives have a way of making dilution feel painless right up until the moment it isn't.